Biotech Values

[olddogwithnewtrix]

I have said repeatedly (not on this board) that I gave 797 zero value. I think it is funny that the stock is selling off in after hours. I do not like pain drug trials -especially competing with oxy. (who doesn't like to take an oxy while in pain LOL)

IMHO The sleeper value for ARRY is 614. In the presentation on 12/16/11 towards the very end the VP said that 4 of 7 platelet deficit patients that were transfusion dependent became transfusion independent while taking the drug. This is interesting because MDS patients that are transfusion independent live far longer than their dependent counterparts.
There is a good possibility 614 will offer a durable, beneficial response for many with MDS. They will give an update on the dose escalation study at ASH in December , I am bullish on the new formulation.

Then you have all the cancer drugs to fall back on. Lots of chances with this one.